Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters
Database
Type of study
Language
Document Type
Year range
1.
Safety and efficacy of graded dosing of Pfizer-BioNTech mRNA COVID-19 vaccine after an immediate hypersensitivity reaction to first dose.
Regula, Prudhvi; Rosenstreich, David; Jerschow, Elina; Ramesh, Manish; Ferastraoaru, Denisa; Oh, Jessica; Aivazi, Daniella S; Aivazi, Jonathan M; Hudes, Golda.
J Allergy Clin Immunol Glob ; 1(3): 175-177, 2022 Aug.
Article in English | MEDLINE | ID: covidwho-1814605

ABSTRACT

Current guidelines do not recommend subsequent mRNA COVID-19 vaccination in patients who experience immediate allergic reactions to the first dose. Our findings indicate that graded dosing of this vaccine is safe, efficacious, and useful for treating these individuals with allergy.

SEND TO:
Email
Export
Print
RSS
XML
SELECTION OF CITATIONS
SEARCH DETAIL